| 查看: 1371 | 回复: 13 | |||
[交流]
美国 University of Nebraska-Lincoln 全奖招博士研究生 (Biomedical area)
|
|
Dr. Jiujiu Yu from the Department of Nutrition and Health Sciences at the University of Nebraska Lincoln is recruiting a highly-motivated Ph.D. student for Fall 2022. Our broad research interests are to 1) investigate the molecular mechanisms of NLRP3 inflammasome activation in the innate immune cells; 2) study the role of NLRP3 inflammasome-mediated chronic inflammation in obesity, aging, and liver diseases; and 3) identify new molecular nutraceuticals to suppress such inflammation (https://cehs.unl.edu/nhs/yu-lab/). Minimum qualification includes an M.S. or equivalent degree in biology, biochemistry, nutrition, or related field. Previous research experience in one or more of the following areas (obesity, liver diseases, extracellular vesicles, dietary molecules, mouse models, microbiome) is highly desirable. If interested, please submit your CV and personal statement to Dr. Yu at jyu18@unl.edu please indicate your GPA, TOEFL, and GRE scores in your application. Your application will not be considered without a personal statement or the aforementioned scores. Department requirement: Grade point average of 3.0 or higher on a 4.0 scale. Preferred minimum GRE scores: 145 Verbal; 150 Quantitative; 3.0 Analytical (writing). Required minimum TOEFL score (International students only): 550 paper; 79 internet; or 6.5 IELTS. https://cehs.unl.edu/nhs/graduate-programs/#tab0 |
» 猜你喜欢
282求调剂
已经有6人回复
271求调剂
已经有7人回复
【求调剂】293分环境工程求调剂材料/化工,服从调剂,抗压能力强!
已经有7人回复
085600材料与化工,一志愿广州985,求调剂
已经有6人回复
求材料调剂
已经有4人回复
复试调剂
已经有5人回复
085600,一志愿郑州大学,280分求调剂
已经有3人回复
085602 293分求调剂
已经有3人回复
A区一本交叉课题组,低分调剂,招收机械电子信息通信等交叉方向
已经有24人回复
材料调剂
已经有4人回复
蝉123456
新虫 (知名作家)
- 应助: 0 (幼儿园)
- 金币: 8621.2
- 散金: 7625
- 沙发: 17
- 帖子: 8492
- 在线: 80.3小时
- 虫号: 25711072
- 注册: 2021-03-08
- 专业: 计算机软件
2楼2022-02-03 19:32:33
3楼2022-02-05 06:09:36
4楼2022-02-06 11:46:10
5楼2022-02-07 01:41:04
6楼2022-02-09 03:10:13
7楼2022-02-10 03:58:07
8楼2022-02-10 23:34:59
9楼2022-02-12 00:00:36
10楼2022-02-13 08:50:05













回复此楼